Doximity is the leading digital platform for U.S. medical professionals, operating a verified clinical membership network that includes over 80% of U.S. physicians across all specialties and practice areas. The platform provides workflow tools built for medicine, including secure messaging, digital faxing, telehealth (Doximity Dialer), career management, scheduling, and curated medical news. Doximity monetizes primarily through pharmaceutical manufacturer marketing solutions, hospital recruiting, and telehealth subscriptions. The company went public on the NYSE in June 2021 under the ticker DOCS.
Doximity is publicly traded
IPO'd on June 24, 2021
This company is no longer available on our private secondary market. Shares can be traded publicly under DOCS.
Company data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.
Founded
2010
Employees
830–919
Total Funding
$81.8M
3 rounds
Last Private Valuation
$0.08B
April 29, 2014
Total raised $81.8M across 3 rounds
Funding data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.
Last updated 06-25-2026
Latest Round
Type
Series B
Date
October 11, 2012
Amount
$17M
Valuation
$0.08B
Lead Investors
| Date | Round | Amount Raised | Valuation | Lead Investors |
|---|---|---|---|---|
| April 29, 2014 | Series C | $54M | — | Draper Fisher Jurvetson, T. Rowe Price |
| October 11, 2012 | Series B | $17M | $0.08B | Morgenthaler Ventures |
| March 16, 2011 | Series A | $10.8M | $0.04B | Emergence Capital Partners, InterWest Partners |
Valuation indexed to 1.0× at the selected entry round. Valuation marks are estimates and may contain errors. Hover each dot to compare.
Entry · Series A
$0.0B
Mar 2011
Doximity today
$0.1B
Oct 2012 · latest mark
Doximity multiple
2.1x
valuation uplift since first round
Y-axis is logarithmic. Hollow dots = estimated valuations. Does not represent realized investor returns.
Jeff Tangney
Co-Founder, Chief Executive Officer & Chairperson
Nate Gross
Co-Founder & Chief Strategy Officer
Shari Buck
Co-Founder & SVP, People & Operations
Matt Sonnefeld
Chief Financial Officer
Steve Zatz
President
Jey Balachandran
Chief Technology Officer
Competitor list is illustrative and may be incomplete, stale, or erroneous.
Sermo
Global peer-to-peer physician social network focused on clinical case discussions, second opinions, and paid medical surveys for HCPs.
Figure 1
Mobile-first medical image-sharing and case discussion platform for healthcare professionals worldwide.
Medscape
WebMD-owned clinical reference, medical news, and CME platform with a large physician audience, competing for HCP advertising spend.
General professional network owned by Microsoft; competes with Doximity for physician recruiting and HCP-targeted marketing.
PulsePoint
Health-focused programmatic advertising and audience data platform for pharma marketers reaching HCPs and consumers.
Yes, Doximity is publicly traded under the ticker symbol DOCS on the NYSE. The company went public in June 24, 2021.
Doximity trades under the ticker symbol DOCS on the NYSE. It began trading in June 24, 2021.
Doximity (DOCS on the NYSE) shares can be purchased through any standard brokerage account — including Fidelity, Charles Schwab, TD Ameritrade, and online platforms like Robinhood or E*TRADE. Search for the ticker DOCS to place an order.
Doximity went public in June 24, 2021 via ipo, with an offering valuation of approximately $0.08B. Doximity completed its IPO on the NYSE on June 24, 2021 under ticker DOCS, pricing an upsized offering of 23.3M Class A shares at $26.00 (above the $20-23 range). Shares opened at $41.17 and closed the first day at $53, more than doubling the IPO price and giving the company a market cap of approximately $9.4 billion on day one. The IPO raised approximately $605.8 million in gross proceeds. The company trades publicly on NYSE as DOCS.
Doximity raised $81.8M across 3 disclosed funding rounds prior to its public listing.
Doximity was co-founded by Jeff Tangney, Nate Gross, and Shari Buck in 2010.
Doximity is headquartered in San Francisco, CA.
Access live market data
Sign UpData collected with AI, which can make mistakes. Please double-check this information.